These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 596517)

  • 1. Identification and neutralization of biological activities associated with venom from the brown recluse spider, Loxosceles reclusa.
    Futrell JM; Morgan PN
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 1):1206-11. PubMed ID: 596517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of complement by Loxosceles reclusa spider venom.
    Gebel HM; Finke JH; Elgert KD; Cambell BJ; Barrett JT
    Am J Trop Med Hyg; 1979 Jul; 28(4):756-62. PubMed ID: 464196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro model for studying hemolysis associated with venom from the brown recluse spider (Loxosceles reclusa).
    Futrell JM; Morgan BB; Morgan PN
    Toxicon; 1979; 17(4):355-62. PubMed ID: 494317
    [No Abstract]   [Full Text] [Related]  

  • 4. Location of brown recluse venom attachment sites on human erythrocytes by the firritin-labeled antibody technique.
    Futrell JM; Morgan PN; Su SP; Roth SI
    Am J Pathol; 1979 Jun; 95(3):675-82. PubMed ID: 377995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of human erythrocytes by venom from the brown recluse spider, Loxosceles reclusa.
    Morgan BB; Morgan PN; Bowling RE
    Toxicon; 1978; 16(1):85-8. PubMed ID: 622732
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of human complement components by Loxosceles reclusa venom.
    Futrell JM; Morgan PN
    Int Arch Allergy Appl Immunol; 1978; 57(3):275-8. PubMed ID: 659016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism?
    Rees RS; Nanney LB; Yates RA; King LE
    J Invest Dermatol; 1984 Oct; 83(4):270-5. PubMed ID: 6481179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternate complement pathway activation by recluse spider venom.
    Kurpiewski G; Campbell BJ; Forrester LJ; Barrett JT
    Int J Tissue React; 1981 Mar; 3(1):39-45. PubMed ID: 7287056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative toxinology of Loxosceles reclusa and Corynebacterium pseudotuberculosis.
    Bernheimer AW; Campbell BJ; Forrester LJ
    Science; 1985 May; 228(4699):590-1. PubMed ID: 3983643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isotachophoretic and immunological analysis of venoms from sea snakes (Laticauda semifasciata) and brown recluse spiders (Loxosceles reclusa) of different morphology, locality, sex, and developmental stages.
    Kent CG; Tu AT; Geren CR
    Comp Biochem Physiol B; 1984; 77(2):303-11. PubMed ID: 6697691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brown Recluse spider bite mediated hemolysis: clinical features, a possible role for complement inhibitor therapy, and reduced RBC surface glycophorin A as a potential biomarker of venom exposure.
    Gehrie EA; Nian H; Young PP
    PLoS One; 2013; 8(9):e76558. PubMed ID: 24086749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the brown recluse spider bite.
    Rees R; Shack RB; Withers E; Madden J; Franklin J; Lynch JB
    Plast Reconstr Surg; 1981 Nov; 68(5):768-73. PubMed ID: 7291346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antiserum on the systemic response in mice caused by a component isolated from an extract of the brown recluse spider (Loxosceles reclusa) venom apparatus.
    Beckwith ML; Babcock JL; Geren CR
    Toxicon; 1980; 18(5-6):663-6. PubMed ID: 7222071
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic and hemolytic properties of brown recluse spider (Loxosceles reclusa) toxin and extracts of venom apparatus, cephalothorax and abdomen.
    Rekow MA; Civello DJ; Geren CR
    Toxicon; 1983; 21(3):441-4. PubMed ID: 6353666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of a 35-kilodalton purified protein from Loxosceles intermedia spider venom transforms human erythrocytes into activators of autologous complement alternative pathway.
    Tambourgi DV; Magnoli FC; Von Eickstedt VR; Benedetti ZC; Petricevich VL; da Silva WD
    J Immunol; 1995 Nov; 155(9):4459-66. PubMed ID: 7594608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of venom from the brown recluse spider (Loxosceles reclusa) on human neutrophils.
    Majeski JA; Stinnett JD; Alexander JW; Durst GG
    Toxicon; 1977; 15(5):423-7. PubMed ID: 906025
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and characterization of a toxin from brown recluse spider (Loxosceles reclusa) venom gland extracts.
    Babcock JL; Civello DJ; Geren CR
    Toxicon; 1981; 19(5):677-89. PubMed ID: 7302957
    [No Abstract]   [Full Text] [Related]  

  • 20. Incompatibility associated with the bite of a brown recluse spider (Loxosceles reclusa).
    Hardman JT; Beck ML; Hardman PK; Stout LC
    Transfusion; 1983; 23(3):233-6. PubMed ID: 6407159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.